Anticancer potential of 3-(Arylideneamino)-2-phenylquinazoline-4(3H)-one derivatives

Cellular Physiology and Biochemistry

Volumn 29, Issue 1-2, 2012, Pages 251-260

  Das, Subhadip ^a   Chatterjee, Nabanita ^a   Bose, Dipayan ^a   Dey, Sumit Kr ^a   Munda, Rudra Narayan ^a   Nandy, Abhishek ^a   Bera, Sanjoy ^b   Biswas, Shyamal Kr ^b   Saha, Krishna Das ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Calcutta Institute of Pharmaceutical Technology and AHS   (India)

Author keywords

Anti tumor; Apoptosis; Quinazolinone derivatives

Indexed keywords

3 (ARYLIDENEAMINO) 2 PHENYLQUINAZOLIN 4(3H) ONE DERIVATIVE; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; CYTOCHROME C; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL STRAIN HCT116; CELL STRAIN HEPG2; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DRUG SYNTHESIS; HELA CELL; HUMAN; HUMAN TISSUE; MELANOMA; MELANOMA B16; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR VOLUME;

MUS;

EID: 84859867737     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000337606     Document Type: Article

References (22)

1. Parasi K, Bhattacharya D, List J: The dreaded disease: cancer in the developing world. Hastings Cent Rep 2011;41:13-14.
2. Ellis RE, Yuan JY, Horvitz HR: Mechanisms and functions of cell death. Annu Rev Cell Biol 1991;7:663-698.
3. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
4. Hotz M, Gong J, Traganos F, Darzykiewicz Z: Flow cytometric detection of apoptosis: comparison of the assay of in situ DNA degradation and chromatin changes. Cytometry 1994;15:237-244.
5. Chen M, Wang J: Initiator caspases in apoptosis signalling pathways. Apoptosis 2002;7:313-319. (Pubitemid 34832255)
6. Thornberry NA, Lazebnik Y: Caspases: enemies within. Science 1998;281:1312-1316. (Pubitemid 28406817)
7. Cryns V, Yuan J: Proteases to die for. Genes Dev 1998;12:1551-1570. (Pubitemid 28299508)
8. Alagarsamy V, Giridhar R, Yadav HR, Revathi R, Rukmani K, Clercq DE: Anti HIV, antibacterial and antifungal activities of some novel 1,4-disubstituted-1, 2,4-triazolo[4,3a]quinazolin-5(4H)-ones. Indian J Pharm Sci 2006;68:532-535. (Pubitemid 44599839)
9. Srivastava VK, Singh A, Gucati A, Shankar K: Antiparkinsonian agent from quinazolinyl thioazolidinones and azetidinones. Indian J Chem 1987;26:652-656.
10. Gupta D, Ahmed P, Kumar S, Shankar AK: Newer quinazolinone derivatives as anthelmintic agents. Indian J Chem 1988;27:1060-1062.
11. Jatav V, Mishra P, Kaswa S, Stabes JP: Synthesis and CNS depressant activity of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones. Eur J Med Chem 2008;43:135-141.
12. Joshi V, Chaurasia RP: Synthesis of some new 4-quinazolinone-2- carboxylhydrazides and their tosyl derivatives having potential biological activity. Indian J Chem 1987;26:602-604.
13. Abdel-Rahman TM: Synthesis of some new biologically active 2, 3-disubstituted quinazolin-4-ones. Boll Chim Farm 1998;137:43-47. (Pubitemid 128497426)
14. Farghaly AM, Chaaban I, Khalil MA, Bekhit AA: Nonsteroidal antiinflammatory agents. Synthesis of novel 2-pyrazolyl-4(3H)-quinazolinones. Arch Pharmacol 1990;323:833-836. (Pubitemid 20369789)
15. Kornet MJ: Synthesis and anticonvulsant activity of 3-alkyl-3,4-dihydro- 2(1H)-quinazolinones. J Heterocyclic Chem 1992;29:103-105.
16. Jantova S, Urbancikova M, Maliar T, Mikulasova M, Rauko P, Cipak L, Kubikova J, Stankovsky S, Spirkova K: Biological activity of some 4-anilinoquinazolines: cytotoxic, genotoxic and antiprotease effects, induction of necrosis and changes of actin cytoskeleton. Neoplasma 2001;48:52-60. (Pubitemid 32167707)
17. Hamel E, Lin CM, Plowman J: Antitumour 2,3-dihydro-2-(aryl)-4(1H)- quinazolinone derivatives. Interactions with tubulin. Biochem Pharmacol 1996;51:53-59.
18. Huang S, Armstrong EA, Benavente S: Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor. Cancer Res 2004;64:5355-5362. (Pubitemid 39006556)
19. Holden SA, Teicher BA, Robinson MF: Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo. Cancer Chemother Pharmacol 1995;36:165-171.
20. Jantova1 S, Repicky A, Paulovicova E, Letasiova1 S, Cipak L: Antiproliferative activity and apoptosis induced by 6-bromo -2 -(morpholin-1-yl ) -4 -anilinoquinazoline on cells of leukemia lines. Exp Oncol 2008;30:139-142. (Pubitemid 351951391)
21. Ovadekova R, Jantova S, Theiszov M, Labuda J: Cytotoxicity and detection of damage to DNA by 3-(5-nitro-2-thienyl)-9-chloro-5-morpholin-4-yl[1,2,4] triazolo[4,3-c]quinazoline on human cancer cell line HeLa. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005;149:455-459.
22. Chandrika PM, Yakaiah T, Narsaiah B, Sridhar V, Venugopal G, Venkateshwara Rao J, Kumar KP, Murthy USN, Ram Rao AR: Synthesis leading to novel 2,4,6-trisubstituted quinazoline derivatives, their antibacterial and cytotoxic activity against THP-1, HL-60 and A375 cell lines. Indian J Chem 2009;48:840-847.